Posters

Anterior chamber foldable phakic IOL: safety and efficacy

Poster Details

First Author: A. Hasan EGYPT

Co Author(s):                        

Abstract Details

Purpose:

To assess the visual outcome stability and safety of eyes undergoing Anterior chamber foldable phakic lens implantation(Artiflex) (Ophtec BV, Groningen, The Netherlands) or ( veriflex) (AMO,Santa Ana,CA) for myopia unsuitable for LASIK and detection of early and late complications along three years follow up period.

Setting:

Sohag Faculty of Medicine, Egypt

Methods:

Retrospective analysis of 25 eyes of 16 patients underwent Anterior chamber foldable phakic IOL(Artiflex) or ( Veriflex) implantation for correction of myopia all patients were unsuitable for LASIK all patients underwent surgery with one surgeon in same circumstances. Uncorrected visual acuity, corrected visual acuity, higher-order aberrations, patient satisfaction, central endothelial cell count, and PIOL position centration and incarcerated iris tissue were determined along follow up period.

Results:

A total of 25 eyes from 16 patients were reviewed. Follow-up for 36. At final follow-up, 14 of the 25 eyes (56 %) achieved best-corrected visual acuity (BCVA) better than that measured pre-operatively and 10 of the 25 eyes (40%) matched their pre-operative BCVA. 1 eyes, (4 %) attained a final BCVA worse than pre-operatively, one due to recurrent uveitis only one patient (4%) need another surgery to refixate the lens due to slippage of incarcerated iris tissue with impending displacement.

Conclusions:

This study suggests that Anterior chamber foldable phakic IOL (iris claw lens insertion) Ariflexor Veriflex is beneficial in myopia , unsuitable for LASIK , matching or exceeding pre-operative BCVA in the overwhelming majority of the cases. With no major complications however long standing follow up is needed to avoid major complications.

Financial Disclosure:

NONE